Jazz Pharmaceuticals
JAZZ
#1986
Rank
S$11.03 B
Marketcap
$182.51
Share price
1.25%
Change (1 day)
7.49%
Change (1 year)

Earnings for Jazz Pharmaceuticals (JAZZ)

Earnings in 2024 (TTM): S$0.52 Billion

According to Jazz Pharmaceuticals's latest financial reports the company's current earnings are S$3.99 Billion. In 2023 the company made an earning of S$0.39 Billion, an increase over its 2022 earnings that were of -S$0.5 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Jazz Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.52 B31.53%
2023 S$0.39 B-179.92%
2022 -S$0.5 Billion230.37%
2021 -S$0.16 Billion-141.02%
2020 S$0.36 B-39.45%
2019 S$0.60 B-14.2%
2018 S$0.70 B20.03%
2017 S$0.58 B-17.15%
2016 S$0.71 B22.14%
2015 S$0.58 B187.64%
2014 S$0.20 B-50.79%
2013 S$0.41 B73.63%
2012 S$0.23 B41.69%
2011 S$0.16 B116.61%
2010 S$77.18 M262.77%
2009 S$21.27 M-111.33%
2008 -S$0.19 Billion1.31%
2007 -S$0.19 Billion77.8%
2006 -S$0.11 Billion36.59%
2005 -S$76.32 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$3.2 Billion-699.99%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$2.80 B 425.95%๐Ÿ‡บ๐Ÿ‡ธ USA
S$18.21 B 3,321.48%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-S$0.38 Billion-170.74%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel